Medication info

Omethin Neo Syrup (Amoxicillin·Clavulanate Potassium (14:1))

Prescription medicationSyrupOralExpired
Ingredient · strength
Amoxicillin Hydrate›54.545g / 100gDilute Potassium Clavulanate›7.8g / 100g
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
A syrup preparation in white or light yellow powder that is dissolved before use
Packaging
50ml - 50 milliliters per bottle
Approval status
Expired

MFDS item code 201900910 · Notified 2019.02.13

This product's status changed to Expired on 2024.01.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children
Who takes it
Adults · Children
Adult dose
○ Adults: There is no experience with the use of this medicine in adults. ○ Patients with hepatic impairment: Use this medicine with caution in patients with hepatic impairment and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medicine at the beginning of a meal. Administration at the beginning of a meal increases the absorption of potassium clavulanate.
Child dose
○ Pediatric patients aged 3 months and older: The recommended dose of this medicine, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day in divided doses every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8kg: Administer 3.0mL every 12 hours 12kg: Administer 4.5mL every 12 hours 16kg: Administer 6.0mL every 12 hours 20kg: Administer 7.5mL every 12 hours 24kg: Administer 9.0mL every 12 hours 28kg: Administer 10.5mL every 12 hours 32kg: Administer 12.0mL every 12 hours 36kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medicine in pediatric patients weighing 40kg or more.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of recurrent or persistent acute otitis media and recurrent acute sinusitis in children

  • Recurrent acute otitis media
  • persistent acute otitis media
  • recurrent acute sinusitis
View approved original text

This medication is effective against major bacteria such as Streptococcus pneumoniae, Haemophilus influenzae (including beta-lactamase producing strains), and Moraxella catarrhalis (including beta-lactamase producing strains). It is primarily used for the treatment of recurrent or persistent acute otitis media and acute sinusitis in children under 2 years of age who have a history of antibiotic use for acute otitis media or acute sinusitis within the past 3 months, or in children attending daycare. Thus, it helps effectively treat these infectious diseases in young patients and improve symptoms.

How to take

Adult dose

○ Adults: There is no experience with the use of this medicine in adults. ○ Patients with hepatic impairment: Use this medicine with caution in patients with hepatic impairment and monitor liver function regularly. ○ To minimize the possibility of gastrointestinal disturbances, administer this medicine at the beginning of a meal. Administration at the beginning of a meal increases the absorption of potassium clavulanate.

Child dose

○ Pediatric patients aged 3 months and older: The recommended dose of this medicine, based on the amoxicillin content (600 mg/5 mL), is 90mg/kg/day in divided doses every 12 hours. Administer for 10 days for acute otitis media and for 7 days for acute sinusitis. 8kg: Administer 3.0mL every 12 hours 12kg: Administer 4.5mL every 12 hours 16kg: Administer 6.0mL every 12 hours 20kg: Administer 7.5mL every 12 hours 24kg: Administer 9.0mL every 12 hours 28kg: Administer 10.5mL every 12 hours 32kg: Administer 12.0mL every 12 hours 36kg: Administer 13.5mL every 12 hours ○ Pediatric patients weighing 40kg or more: There is no experience with the use of this medicine in pediatric patients weighing 40kg or more.

Precautions

This medication should not be used in patients who have had a hypersensitivity reaction to specific ingredients or beta-lactam antibiotics. Caution should be exercised for patients with viral infections such as infectious mononucleosis or lymphocytic leukemia due to a high risk of rash. Patients with a history of liver dysfunction or jaundice caused by this medication or penicillin class drugs should not be administered due to the risk of recurrence. Patients with lactose intolerance or certain genetic metabolic disorders should not take this medication due to the lactose content. Patients with impaired liver function should be careful as this medication may worsen liver function. Moderate or severe renal impairment patients should adjust dosing intervals since the drug may remain in the body for a long time, increasing the risk of side effects. Patients with allergies or symptoms such as asthma or hives should be cautious as hypersensitivity reactions may occur with this medication. Patients unable to eat properly or in poor nutritional status, and elderly patients should be careful as symptoms of vitamin K deficiency may appear. Patients with gastrointestinal symptoms like vomiting or diarrhea should be cautious as drug absorption may be impaired. This medication generally has few side effects, but contact dermatitis, diarrhea, vomiting, and rashes may occur and should be discontinued in severe cases. Gastrointestinal adverse reactions may include diarrhea, abdominal pain, and vomiting, and if gastrointestinal disturbances are severe, consulting a physician is advised. Liver dysfunction may occur, especially in elderly patients or with prolonged use, necessitating regular liver function tests. Severe skin reactions or allergic reactions can rarely occur; if a rash or itching arises, the physician should be notified immediately. Blood-related abnormalities such as leukopenia and thrombocytopenia may occur, so regular blood tests may be necessary. Central nervous system symptoms such as agitation, anxiety, dizziness, and rarely seizures may occur; any abnormal symptoms should be reported promptly. Careful monitoring is required for patients with kidney disease as it may affect kidney function. During antibiotic treatments, infections from other bacteria or fungi may arise; if symptoms worsen, consulting a physician is necessary. This medication should only be used for the necessary duration to prevent resistance to infecting bacteria, and it should not be arbitrarily discontinued. Shake well before use, and store in a refrigerator after preparation, and consume all within 7 days. Women who are pregnant or may become pregnant should avoid using this medication during the first 3 months, and nursing mothers should be cautious as adverse reactions may occur in the infant. Children under 3 months should not be used as safety has not been established. Inform the physician or pharmacist of any other medications being taken to avoid potential interactions. In cases of overdose, symptoms such as vomiting, diarrhea, and kidney damage may occur, requiring immediate contact with healthcare personnel for appropriate treatment. This medication should only be used for bacterial infections and is ineffective against viral infections like the common cold, so it should only be taken when necessary.

Side effects

Contact dermatitis, diaper rash, diarrhea, vomiting, moniliasis, rash, pseudomembranous colitis, indigestion, stomatitis, gastritis, glossitis, black hairy tongue, nausea, anorexia, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, loose stools, dry mouth, candidiasis, antibiotic-induced colitis, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized exanthematous pustulosis, eosinophilia, drug reaction (DRESS), angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, reversible leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vulvar itching, burning sensation, increased secretions, anxiety, restlessness, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B deficiency, tooth discoloration, dysgeusia, malaise, dermatitis, oral swelling, gastric pain, disturbance of fluid and electrolyte balance, hyperactivity, drowsiness, interstitial nephritis, interstitial cerebral convulsions, hypersensitivity shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, keeping it in a dry place below 25 degrees Celsius will help maintain its effectiveness for a longer period.

Appearance and packaging

Appearance

A syrup preparation in white or light yellow powder that is dissolved before use

Package unit

50ml - 50 milliliters per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.